S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Is AMC Entertainment Pulling a Fast One on the APEs?
Is Apple Pointing to a Massive Recession in the U.S.? (Ad)
Boredom, loneliness plague Ukrainian youth near front line
Here is a Simple 4 Stock Portfolio that Can Outperform the Market
High oil prices help Saudi Aramco earn $88B in first half
Is Apple Pointing to a Massive Recession in the U.S.? (Ad)
Ship carrying grain for hungry Ethiopia leaves Ukraine
Here’s How the Inflation Reduction Act Energizes Power Stock
Average US gasoline price falls 45 cents to $4.10 per gallon
Is Apple Pointing to a Massive Recession in the U.S.? (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Is AMC Entertainment Pulling a Fast One on the APEs?
Is Apple Pointing to a Massive Recession in the U.S.? (Ad)
Boredom, loneliness plague Ukrainian youth near front line
Here is a Simple 4 Stock Portfolio that Can Outperform the Market
High oil prices help Saudi Aramco earn $88B in first half
Is Apple Pointing to a Massive Recession in the U.S.? (Ad)
Ship carrying grain for hungry Ethiopia leaves Ukraine
Here’s How the Inflation Reduction Act Energizes Power Stock
Average US gasoline price falls 45 cents to $4.10 per gallon
Is Apple Pointing to a Massive Recession in the U.S.? (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Is AMC Entertainment Pulling a Fast One on the APEs?
Is Apple Pointing to a Massive Recession in the U.S.? (Ad)
Boredom, loneliness plague Ukrainian youth near front line
Here is a Simple 4 Stock Portfolio that Can Outperform the Market
High oil prices help Saudi Aramco earn $88B in first half
Is Apple Pointing to a Massive Recession in the U.S.? (Ad)
Ship carrying grain for hungry Ethiopia leaves Ukraine
Here’s How the Inflation Reduction Act Energizes Power Stock
Average US gasoline price falls 45 cents to $4.10 per gallon
Is Apple Pointing to a Massive Recession in the U.S.? (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Is AMC Entertainment Pulling a Fast One on the APEs?
Is Apple Pointing to a Massive Recession in the U.S.? (Ad)
Boredom, loneliness plague Ukrainian youth near front line
Here is a Simple 4 Stock Portfolio that Can Outperform the Market
High oil prices help Saudi Aramco earn $88B in first half
Is Apple Pointing to a Massive Recession in the U.S.? (Ad)
Ship carrying grain for hungry Ethiopia leaves Ukraine
Here’s How the Inflation Reduction Act Energizes Power Stock
Average US gasoline price falls 45 cents to $4.10 per gallon
Is Apple Pointing to a Massive Recession in the U.S.? (Ad)
TSE:MBX

Microbix Biosystems - MBX Stock Forecast, Price & News

C$0.52
0.00 (0.00%)
(As of 08/12/2022 09:16 PM ET)
Add
Compare
Today's Range
C$0.50
C$0.52
50-Day Range
C$0.44
C$0.55
52-Week Range
C$0.41
C$0.87
Volume
9,500 shs
Average Volume
59,944 shs
Market Capitalization
C$71.20 million
P/E Ratio
17.33
Dividend Yield
N/A
Price Target
N/A
MBX stock logo

About Microbix Biosystems (TSE:MBX) Stock

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. It manufactures a range of critical biological materials for the diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment and proficiency (QAPs) that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows. The company also applies its biological expertise and infrastructure to develop other proprietary products, primarily viral transport medium (DxTM) to stabilize patient samples for lab-based testing and Kinlytic Urokinase, a biologic thrombolytic drug used to treat blood clots. It sells QAPs to lab accreditation organizations, diagnostics companies, and clinical labs through a network of regional distributors. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.

Analyst Ratings Changes

Separately, Bloom Burton restated a "buy" rating on shares of Microbix Biosystems in a research note on Monday, June 6th.

Microbix Biosystems Price Performance

Shares of TSE:MBX remained flat at C$0.52 during trading hours on Friday. The company had a trading volume of 9,500 shares, compared to its average volume of 59,944. The stock has a fifty day moving average price of C$0.50 and a two-hundred day moving average price of C$0.54. The company has a current ratio of 6.49, a quick ratio of 4.71 and a debt-to-equity ratio of 26.68. The company has a market capitalization of C$71.20 million and a P/E ratio of 17.33. Microbix Biosystems has a twelve month low of C$0.41 and a twelve month high of C$0.87.

Microbix Biosystems (TSE:MBX - Get Rating) last announced its quarterly earnings results on Thursday, May 12th. The company reported C$0.01 earnings per share for the quarter. The company had revenue of C$4.88 million during the quarter. Sell-side analysts forecast that Microbix Biosystems will post 0.04 earnings per share for the current fiscal year.

Insider Transactions at Microbix Biosystems

In other news, Director Cameron Lionel Groome sold 65,000 shares of the company's stock in a transaction on Wednesday, July 20th. The stock was sold at an average price of C$0.52, for a total transaction of C$33,540.00. Following the transaction, the director now owns 625,000 shares of the company's stock, valued at C$322,500.

Receive MBX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Microbix Biosystems and its competitors with MarketBeat's FREE daily newsletter.

MBX Stock News Headlines

Microbix Reports Results for Q3 Fiscal 2022
Microbix Executes Substantial QAPs Supply Agreement
Microbix Reports Record Results for Q2 Fiscal 2022
Microbix Presenting HPV Product Results at EUROGIN
Microbix Invests to Further Scale Its Business
Microbix Announces Nomination to Board of Directors
Microbix Reports Record Results for Q1 Fiscal 2022
Microbix Launches Omicron Variant Test Control
Microbix, Nubeva at 52-Week Highs on News
Microbix Reports Record Results for Fiscal 2021
Microbix Launches Multiplex Respiratory PCR-Test Control
Microbix Receives $2.7 Million from Exercise of Warrants
Microbix Makes Early Repayment of 9% Interest Debenture
See More Headlines
Receive MBX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Microbix Biosystems and its competitors with MarketBeat's FREE daily newsletter.

MBX Company Calendar

Today
8/15/2022
Next Earnings (Estimated)
12/22/2022

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$20.82 million
Cash Flow
C$0.09 per share
Book Value
C$0.17 per share

Miscellaneous

Free Float
N/A
Market Cap
C$71.20 million
Optionable
Not Optionable
Beta
N/A














MBX Stock - Frequently Asked Questions

Should I buy or sell Microbix Biosystems stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Microbix Biosystems in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" MBX shares.
View MBX analyst ratings
or view top-rated stocks.

How have MBX shares performed in 2022?

Microbix Biosystems' stock was trading at C$0.83 on January 1st, 2022. Since then, MBX stock has decreased by 37.3% and is now trading at C$0.52.
View the best growth stocks for 2022 here
.

When is Microbix Biosystems' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, December 22nd 2022.
View our MBX earnings forecast
.

What other stocks do shareholders of Microbix Biosystems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Microbix Biosystems investors own include TransAlta Renewables (RNW), OrganiGram (OGI), Dynavax Technologies (DVAX), Heat Biologics (HTBX), VEON (VEON), Vaxart (VXRT), Wajax (WJX), BlackBerry (BB) and Canadian Western Bank (CWB).

What is Microbix Biosystems' stock symbol?

Microbix Biosystems trades on the Toronto Stock Exchange (TSX) under the ticker symbol "MBX."

How do I buy shares of Microbix Biosystems?

Shares of MBX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Microbix Biosystems' stock price today?

One share of MBX stock can currently be purchased for approximately C$0.52.

How much money does Microbix Biosystems make?

Microbix Biosystems (TSE:MBX) has a market capitalization of C$71.20 million and generates C$20.82 million in revenue each year.

How can I contact Microbix Biosystems?

Microbix Biosystems' mailing address is 265 Watline Ave, MISSISSAUGA, ON L4Z 1P3, Canada. The official website for the company is microbix.com. The company can be reached via phone at +1-905-3618910.

This page (TSE:MBX) was last updated on 8/15/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.